Revenue doubled, but Ortin Global remained deeply loss-making
The standalone operating loss narrowed as expenses fell, yet the operating margin remained 893.31 percentage points below the Healthcare peer median.
Filed 11 Nov 2026, 20:44 IST · after market close · Ortin Global Ltd (ORTINGLOBE)
Key takeaways
- Standalone operating loss narrowed to Rs -0.27 cr as revenue rose +200.00% QoQ and expenses fell -11.43%.
- Operating margin improved by 2048.17 percentage points QoQ but remained deeply negative at -871.66%.
- Ortin Global ranked first from the bottom among 90 reported Healthcare peers, versus a sector median operating margin of 21.65%.
Price around the results
Revenue improved, but losses remained
Ortin Global's standalone Q2FY27 results were filed after market close. Revenue rose +200.00% QoQ to Rs 0.03 cr, while the operating loss narrowed to Rs -0.27 cr from Rs -0.34 cr. The improvement reflected higher revenue alongside an -11.43% decline in expenses.
Margin recovery was large but still far below zero
Operating margin widened by 2048.17 percentage points QoQ because revenue grew while expenses declined, but it remained at -871.66%. Other income contributed -3.70% of pre-tax profit, so it did not support the reported loss. The tax rate changed by 0.32 percentage points, with no tax charge reported.
Ortin remained the weakest Healthcare margin reporter
Among 90 Healthcare peers that had reported the same quarter, Ortin Global ranked first from the bottom on operating margin. Its -871.66% margin was 893.31 percentage points below the sector median of 21.65%. With only Q1FY27 available in the trend, the quarter-on-quarter improvement is clear but does not establish a multi-quarter direction.
The market has not yet reacted
The results were filed after market close, so there is no reported stock reaction yet. The next market session will provide the first observable response to the sharp revenue increase and continuing operating loss.
Q2FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 | Q1FY27 | QoQ |
|---|---|---|---|
| Revenue | ₹0 cr | ₹0 cr | +200.00% |
| Other income | ₹0 cr | ₹0 cr | — |
| Expenses | ₹0 cr | ₹0 cr | -11.43% |
| Operating profit | ₹-0 cr | ₹-0 cr | +20.59% |
| Operating margin (%) | -871.66% | -2919.83% | — |
| Interest | ₹0 cr | ₹0 cr | — |
| Depreciation | ₹0 cr | ₹0 cr | — |
| Profit before tax | ₹-0 cr | ₹-0 cr | +18.18% |
| Tax | ₹0 cr | ₹0 cr | — |
| Net profit | ₹-0 cr | ₹-0 cr | +20.59% |
| EPS (₹) | ₹-0.33 | ₹-0.42 | +21.43% |
Operating margin of -871.66% compares with a Healthcare sector median of 21.65% across 90 peers that have reported Q2FY27.
What to watch
- Whether revenue remains above Rs 0.03 cr next quarter.
- Whether expenses stay below Rs 0.31 cr.
- Whether operating margin improves from -871.66%.